ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
Alterity Therapeutics Limited

Alterity Therapeutics Limited (ATHE)

4.80
0.23
(5.03%)
終了 2月1日 6:00AM
4.86
0.06
(1.25%)
取引時間後: 9:59AM

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

主要統計と詳細

通貨
4.86
買値
4.74
売値
4.86
出来高
801,878
4.0901 日の範囲 5.06
0.00 52 週間の範囲 0.00
時価総額
前日終値
4.57
始値
4.55
最終取引時間
財務取引量
US$ 3,629,415
VWAP
4.5261
平均取引量 (3 か月)
-
発行済株式数
8,742,763
配当利回り
-
PER
0.00
1 株当たり利益 (EPS)
-2.19
歳入
4.02M
純利益
-19.12M

Alterity Therapeutics Limited について

Alterity Therapeutics Ltd is active in the healthcare domain. The company is engaged in research collaborations for the treatment of Parkinsonian movement disorders, Alzheimer's disease, Huntington disease, and other neurodegenerative disorders. The company's lead drug candidate-PBT2 is being develo... Alterity Therapeutics Ltd is active in the healthcare domain. The company is engaged in research collaborations for the treatment of Parkinsonian movement disorders, Alzheimer's disease, Huntington disease, and other neurodegenerative disorders. The company's lead drug candidate-PBT2 is being developed for the treatment of Alzheimer's and Huntington's diseases. It has also advanced a drug candidate for Parkinson's disease and other movement disorders (ATH434). 詳細を表示

セクター
Biological Pds,ex Diagnstics
業界
Health Care Diversified
ウェブサイト
本社
Melbourne, Victoria, Aus
設立
1997
Alterity Therapeutics Limited is listed in the Biological Pds,ex Diagnstics sector of the ナスダック市場 with ticker ATHE. The last closing price for Alterity Therapeutics was US$4.57. Over the last year, Alterity Therapeutics shares have traded in a share price range of US$ 0.00 to US$ 0.00.

Alterity Therapeutics currently has 8,742,763 shares in issue. The market capitalisation of Alterity Therapeutics is US$39.95 million. Alterity Therapeutics has a price to earnings ratio (PE ratio) of 0.00.

ATHE 最新ニュース

Alterity Therapeutics Announces Positive ATH434 Phase 2 Trial Results in Multiple System Atrophy Led By Robust Clinical Efficacy

– Clinically Meaningful Benefit Observed at Both ATH434 Doses Studied – – Achieved Statistical Significance with Up to 48% Slowing of Clinical Progression on UMSARS Rating Scale – – Key MRI...

Appendix 4C – Q2 FY25 Quarterly Cash Flow Report

Highlights Topline data for ATH434-201 randomized, double-blind Phase 2 clinical trial on track for expected release by early February 2025ATH434-201 trial in early-stage MSA completed in...

Alterity Therapeutics Issues Shareholder Letter Highlighting Pipeline Advances and Key Upcoming Milestones

MELBOURNE, Australia and SAN FRANCISCO, Jan. 09, 2025 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to...

Alterity Therapeutics Completes Last Patient Visit in ATH434-201 Phase 2 Clinical Trial in Early-Stage Multiple System Atrophy

– ATH434 is a Disease Modifying Drug Candidate Targeting Alpha-Synuclein and Iron in Parkinsonian Disorders – – Topline Data Expected in Early 2025 – MELBOURNE, Australia and SAN FRANCISCO...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
10000000DR
40000000DR
120000000DR
260000000DR
520000000DR
1560000000DR
2600000000DR

ATHE - Frequently Asked Questions (FAQ)

What is the current Alterity Therapeutics share price?
The current share price of Alterity Therapeutics is US$ 4.86
How many Alterity Therapeutics shares are in issue?
Alterity Therapeutics has 8,742,763 shares in issue
What is the market cap of Alterity Therapeutics?
The market capitalisation of Alterity Therapeutics is USD 39.95M
What is the 1 year trading range for Alterity Therapeutics share price?
Alterity Therapeutics has traded in the range of US$ 0.00 to US$ 0.00 during the past year
What is the cash to sales ratio of Alterity Therapeutics?
The cash to sales ratio of Alterity Therapeutics is 0.02
What is the reporting currency for Alterity Therapeutics?
Alterity Therapeutics reports financial results in AUD
What is the latest annual turnover for Alterity Therapeutics?
The latest annual turnover of Alterity Therapeutics is AUD 4.02M
What is the latest annual profit for Alterity Therapeutics?
The latest annual profit of Alterity Therapeutics is AUD -19.12M
What is the registered address of Alterity Therapeutics?
The registered address for Alterity Therapeutics is LEVEL 3, 62 LYGON STREET, CARLTON, MELBOURNE, VICTORIA, 3053
What is the Alterity Therapeutics website address?
The website address for Alterity Therapeutics is www.alteritytherapeutics.com
Which industry sector does Alterity Therapeutics operate in?
Alterity Therapeutics operates in the HEALTH CARE DIVERSIFIED sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
TCTMTCTM Kids IT Education Inc
US$ 0.764
(321.87%)
731.1M
REBNReborn Coffee Inc
US$ 3.31
(63.05%)
55.54M
FCUVFocus Universal Inc
US$ 5.87
(56.62%)
1.73M
SOPASociety Pass Inc
US$ 1.54
(56.50%)
13.87M
CYCNCyclerion Therapeutics Inc
US$ 3.92
(54.33%)
82.57M
ENVBEnveric Biosciences Inc
US$ 2.0899
(-46.41%)
1.58M
NIVFNewGenIvf Group Ltd
US$ 0.1489
(-42.51%)
14.91M
GLSTGlobal Star Acquisition Inc
US$ 8.83
(-39.10%)
23.93k
PRPHProPhase Labs Inc
US$ 0.2633
(-38.02%)
900.48k
SPGCSacks Parente Golf Inc
US$ 0.5601
(-37.86%)
7.42M
TCTMTCTM Kids IT Education Inc
US$ 0.764
(321.87%)
731.1M
NVDANVIDIA Corporation
US$ 120.07
(-3.67%)
388.5M
RIMEAlgorhythm Holdings Inc
US$ 0.02565
(5.12%)
341.8M
CLEUChina Liberal Education Holdings Ltd
US$ 0.1938
(30.77%)
237.15M
BHATBlue Hat Interactive Entertainment Technology
US$ 0.0355
(-11.25%)
236.44M

ATHE Discussion

投稿を表示

最近閲覧した銘柄

Delayed Upgrade Clock